HC Wainwright Cuts Oncolytics Biotech (NASDAQ:ONCY) Price Target to $5.00
Oncolytics Biotech (NASDAQ:ONCY – Free Report) had its price objective cut by HC Wainwright from $15.00 to $5.00 in a research note published on Monday,...
HC Wainwright Cuts MacroGenics (NASDAQ:MGNX) Price Target to $12.00
MacroGenics (NASDAQ:MGNX – Free Report) had its price target trimmed by HC Wainwright from $14.00 to $12.00 in a research note issued to investors on...
Apogee Therapeutics (NASDAQ:APGE) Earns Outperform Rating from Wedbush
Wedbush reaffirmed their outperform rating on shares of Apogee Therapeutics (NASDAQ:APGE – Free Report) in a report released on Monday, RTT News reports. Wedbush currently...
Roth Mkm Begins Coverage on Genasys (NASDAQ:GNSS)
Roth Mkm assumed coverage on shares of Genasys (NASDAQ:GNSS – Free Report) in a research note released on Monday, Benzinga reports. The firm issued a...
Sol-Gel Technologies (NASDAQ:SLGL) Price Target Cut to $9.00 by Analysts at HC Wainwright
Sol-Gel Technologies (NASDAQ:SLGL – Free Report) had its target price decreased by HC Wainwright from $12.00 to $9.00 in a report published on Monday, Benzinga...
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Receives $11.86 Average Target Price from Brokerages
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) has been given an average rating of “Hold” by the ten analysts that are currently covering the...